477 related articles for article (PubMed ID: 17855521)
21. DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.
Grünvogel O; Esser-Nobis K; Reustle A; Schult P; Müller B; Metz P; Trippler M; Windisch MP; Frese M; Binder M; Fackler O; Bartenschlager R; Ruggieri A; Lohmann V
J Virol; 2015 Oct; 89(20):10548-68. PubMed ID: 26269178
[TBL] [Abstract][Full Text] [Related]
22. In vitro replication models for the hepatitis C virus.
Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
[TBL] [Abstract][Full Text] [Related]
23. Serum-free cell culture system supplemented with lipid-rich albumin for hepatitis C virus (strain O of genotype 1b) replication.
Abe K; Ikeda M; Ariumi Y; Dansako H; Kato N
Virus Res; 2007 May; 125(2):162-8. PubMed ID: 17267063
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis A protein VP1-2A reduced cell viability in Huh-7 cells with hepatitis C virus subgenomic RNA replication.
Kanda T; Yokosuka O; Imazeki F; Fujiwara K; Saisho H
J Gastroenterol Hepatol; 2006 Mar; 21(3):625-6. PubMed ID: 16638117
[No Abstract] [Full Text] [Related]
25. The polypyrimidine tract-binding protein (PTB) is required for efficient replication of hepatitis C virus (HCV) RNA.
Chang KS; Luo G
Virus Res; 2006 Jan; 115(1):1-8. PubMed ID: 16102869
[TBL] [Abstract][Full Text] [Related]
26. Production of infectious hepatitis C virus particles in three-dimensional cultures of the cell line carrying the genome-length dicistronic viral RNA of genotype 1b.
Murakami K; Ishii K; Ishihara Y; Yoshizaki S; Tanaka K; Gotoh Y; Aizaki H; Kohara M; Yoshioka H; Mori Y; Manabe N; Shoji I; Sata T; Bartenschlager R; Matsuura Y; Miyamura T; Suzuki T
Virology; 2006 Aug; 351(2):381-92. PubMed ID: 16678876
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction.
Oshiumi H; Ikeda M; Matsumoto M; Watanabe A; Takeuchi O; Akira S; Kato N; Shimotohno K; Seya T
PLoS One; 2010 Dec; 5(12):e14258. PubMed ID: 21170385
[TBL] [Abstract][Full Text] [Related]
28. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.
Watashi K; Ishii N; Hijikata M; Inoue D; Murata T; Miyanari Y; Shimotohno K
Mol Cell; 2005 Jul; 19(1):111-22. PubMed ID: 15989969
[TBL] [Abstract][Full Text] [Related]
29. Viruses and the human DEAD-box helicase DDX3: inhibition or exploitation?
Schröder M
Biochem Soc Trans; 2011 Apr; 39(2):679-83. PubMed ID: 21428961
[TBL] [Abstract][Full Text] [Related]
30. RNAi expression mediated inhibition of HCV replication.
Hamazaki H; Ujino S; Abe E; Miyano-Kurosaki N; Shimotohno K; Takaku H
Nucleic Acids Symp Ser (Oxf); 2004; (48):307-8. PubMed ID: 17150601
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the hepatitis C virus RNA replication complex associated with lipid rafts.
Aizaki H; Lee KJ; Sung VM; Ishiko H; Lai MM
Virology; 2004 Jul; 324(2):450-61. PubMed ID: 15207630
[TBL] [Abstract][Full Text] [Related]
32. Human DEAD-box protein 3 has multiple functions in gene regulation and cell cycle control and is a prime target for viral manipulation.
Schröder M
Biochem Pharmacol; 2010 Feb; 79(3):297-306. PubMed ID: 19782656
[TBL] [Abstract][Full Text] [Related]
33. Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein.
Angus AG; Dalrymple D; Boulant S; McGivern DR; Clayton RF; Scott MJ; Adair R; Graham S; Owsianka AM; Targett-Adams P; Li K; Wakita T; McLauchlan J; Lemon SM; Patel AH
J Gen Virol; 2010 Jan; 91(Pt 1):122-32. PubMed ID: 19793905
[TBL] [Abstract][Full Text] [Related]
34. DEAD-box RNA Helicase DDX3: Functional Properties and Development of DDX3 Inhibitors as Antiviral and Anticancer Drugs.
Kukhanova MK; Karpenko IL; Ivanov AV
Molecules; 2020 Feb; 25(4):. PubMed ID: 32102413
[TBL] [Abstract][Full Text] [Related]
35. Y-Box Binding Protein 1 Stabilizes Hepatitis C Virus NS5A via Phosphorylation-Mediated Interaction with NS5A To Regulate Viral Propagation.
Wang WT; Tsai TY; Chao CH; Lai BY; Wu Lee YH
J Virol; 2015 Nov; 89(22):11584-602. PubMed ID: 26355086
[TBL] [Abstract][Full Text] [Related]
36. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein.
Sato S; Fukasawa M; Yamakawa Y; Natsume T; Suzuki T; Shoji I; Aizaki H; Miyamura T; Nishijima M
J Biochem; 2006 May; 139(5):921-30. PubMed ID: 16751600
[TBL] [Abstract][Full Text] [Related]
37. Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance.
Zhang C; Huys A; Thibault PA; Wilson JA
Virology; 2012 Nov; 433(2):479-88. PubMed ID: 22999255
[TBL] [Abstract][Full Text] [Related]
38. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J
Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546
[TBL] [Abstract][Full Text] [Related]
39. PML tumor suppressor protein is required for HCV production.
Kuroki M; Ariumi Y; Hijikata M; Ikeda M; Dansako H; Wakita T; Shimotohno K; Kato N
Biochem Biophys Res Commun; 2013 Jan; 430(2):592-7. PubMed ID: 23219818
[TBL] [Abstract][Full Text] [Related]
40. Replication and infectivity of a novel genotype 1b hepatitis C virus clone.
Date T; Morikawa K; Tanaka Y; Tanaka-Kaneko K; Sata T; Mizokami M; Wakita T
Microbiol Immunol; 2012 May; 56(5):308-17. PubMed ID: 22320232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
